Nonopioid analgesic use in older patients admitted for orthopedic rehabilitation

Aaron J. Bilek,Stephanie Cullen,Carolyn M. Tan,Qixuan Li,Ella Huszti,Richard E. Norman
DOI: https://doi.org/10.1002/pmrj.13205
2024-06-08
PM&R
Abstract:Background Multimodal analgesia (MMA) combines opioids with nonopioid analgesics (NOAs) to mitigate opioid‐related adverse events and development of opioid use disorders. Although MMA has become the standard for orthopedic perioperative pain management, guidance is less clear for the approximately 15% of patients who go on to require inpatient orthopedic rehabilitation (IOR) postoperatively. The IOR population tends to be older and frailer and hence likely more vulnerable to adverse events. Little research has been done to shed light on how NOAs are used in this population. Objective To characterize NOA prescribing in older versus younger adults during IOR admissions and to determine predictors of NOA prescribing in an older IOR population. Design Retrospective case–control study. Setting Two IOR wards at an academic rehabilitation hospital in Toronto, Canada. Patients All patients aged ≥50 years admitted for an orthopedic indication between November 2019 and June 2021; the patients aged <65 group was included for comparative characterization of NOA prescribing versus older peers. Interventions Not applicable. Main Outcome Measures Medication use and adverse events, pain, and rehabilitation outcomes such as the Functional Independence Measure, discharge destination, and length of stay. Results A total of 643 patient encounters were included; 48.2% used NOA. Age (odds ratio [OR]: 0.97; confidence interval [CI]: 0.95–0.99, p
rehabilitation,sport sciences
What problem does this paper attempt to address?